Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises

Faculty Science Year: 2024
Type of Publication: ZU Hosted Pages:
Authors:
Ahmed Mansour Abdelbaky Abedalaal
Journal: IJMS MDPI Volume:
Keywords : Developing Folate-Conjugated miR-34a Therapeutic , Prostate Cancer:    
Abstract:
Developing Folate-Conjugated miR-34a Therapeutic for Prostate Cancer: Challenges and Promises
    
     
 
       

Author Related Publications

  • Ahmed Mansour Abdelbaky Abedalaal, "A first-in-class fully modified version of miR-34a with outstanding stability, activity, and anti-tumor efficacy", Nature, 2023 More
  • Ahmed Mansour Abdelbaky Abedalaal, "Selective targeting of chemically modified miR-34a to prostate cancer using a small molecule ligand and an endosomal escape agent", Cell, 2024 More
  • Ahmed Mansour Abdelbaky Abedalaal, "Enhancing MicroRNA Activity through Increased Endosomal Release Mediated by Nigericin", Cell, 2019 More
  • Ahmed Mansour Abdelbaky Abedalaal, "Ligand-mediated delivery of RNAi-based therapeutics for the treatment of oncological diseases", Oxford, 2021 More

Department Related Publications

  • Iman Hassan Mohammed Sheikh, "Scanning Electron Microscopic Studies of Gill Arches and Rakers in Relation to Feeding Habits of Some Fresh Water Fishes", Elsevier, 2013 More
  • Ahmed Mohamed Abdelbaky Abedulaal, "Constitutive regulation of mitochondrial morphology by Aurora A kinase depends on a predicted cryptic targeting sequence at the N-terminus", Royal Society_Open Biology 8(6):170272Royal Society, 2018 More
Tweet